Bixiye
QP7-21 Replacement Claim Submission Guidelines
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Natiijooyinka Raadinta
Soo bandhiga 1351 - 1360 ee natiijooyinka 4162
Bixiye
QP6-21 MHCP Pharmacy Benefit Exclusion for OxlumoTM and Danyelza®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP8-21 Change in Suspect COVID-19 Diagnosis Code
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
QP3-21 Commercial and MHCP Pharmacy Benefit Exclusion for Barhemsys® and Monoferric®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
QP123-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2020